Recent studies, relying primarily on human cell culture models of tamoxifen resistant breast cancer cells, have revealed that the acquisition of antiestrogen resistance is associated with emergence of distinct ERα responsive transcriptional programs in breast cancer cells that are associated with genome-wide epigenetic reprogramming of chromatin, including the estrogen responsive enhancer landscape in resistant cells [47–49]. Here, ESR1 is linked to breast cancer.